ArticleFrontiers in oncology2019

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma.

Sanfang Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.